Accumulation of functionally immature myeloid dendritic cells in lymph nodes of rhesus macaques with acute pathogenic simian immunodeficiency virus infection

Immunology

Volumn 143, Issue 2, 2014, Pages 146-154

  Wijewardana, Viskam ^a,c   Bouwer, Anthea L ^a   Brown, Kevin N ^a,d   Liu, Xiangdong ^a,e   Barratt Boyes, Simon M ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Osaka Prefecture University   (Japan)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

AIDS; Apoptosis; Cell proliferation; Viral

Indexed keywords

CCR7 PROTEIN, HUMAN; CD40 ANTIGEN; CHEMOKINE RECEPTOR CCR7; HLA ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; APOPTOSIS; ARTICLE; BLOOD; BONE MARROW CELL; CELL PROLIFERATION; DENDRITIC CELL; FEMALE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LYMPH NODE; MALE; METABOLISM; PATHOGENICITY; PATHOLOGY; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TIME; VIRAL; VIROLOGY;

AIDS; APOPTOSIS; CELL PROLIFERATION; VIRAL;

ANIMALS; ANTIGENS, CD40; APOPTOSIS; CELL PROLIFERATION; DENDRITIC CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HOST-PATHOGEN INTERACTIONS; LYMPH NODES; MACACA MULATTA; MALE; MYELOID CELLS; RECEPTORS, CCR7; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84905996425     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12295     Document Type: Article

References (43)

1. Wonderlich ER, Barratt-Boyes SM. A dendrite in every pie: myeloid dendritic cells in HIV and SIV infection. Virulence 2012; 3:1-7.
2. Derby N, Martinelli E, Robbiani M. Myeloid dendritic cells in HIV-1 infection. Curr Opin HIV AIDS 2011; 6:379-84.
3. Almeida M, Cordero M, Almeida J, Orfao A. Different subsets of peripheral blood dendritic cells show distinct phenotypic and functional abnormalities in HIV-1 infection. AIDS 2005; 19:261-71.
4. Barron MA, Blyveis N, Palmer BE, MaWhinney S, Wilson CC. Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals. J Infect Dis 2003; 187:26-37.
5. Brown KN, Trichel A, Barratt-Boyes SM. Parallel loss of myeloid and plasmacytoid dendritic cells from blood and lymphoid tissue in simian AIDS. J Immunol 2007; 178:6958-67.
6. - plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 2001; 98:2574-6.
7. Grassi F, Hosmalin A, McIlroy D, Calvez V, Debre P, Autran B. Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. AIDS 1999; 13:759-66.
8. Macatonia SE, Lau R, Patterson S, Pinching AJ, Knight SC. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 1990; 71:38-45.
9. + (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood 2001; 98:3016-21.
10. + frequencies that are associated with levels of plasma viremia and T cell activation in an exploratory study. J Virol 2011; 85:397-409.
11. Meera S, Madhuri T, Manisha G, Ramesh P. Irreversible loss of pDCs by apoptosis during early HIV infection may be a critical determinant of immune dysfunction. Viral Immunol 2010; 23:241-9.
12. Dillon SM, Robertson KB, Pan SC et al. Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection. J Acquir Immune Defic Syndr 2008; 48:1-12.
13. + dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection. AIDS 2002; 16:683-92.
14. Wijewardana V, Soloff AC, Liu X, Brown KN, Barratt-Boyes SM. Early myeloid dendritic cell dysregulation is predictive of disease progression in simian immunodeficiency virus infection. PLoS Pathog 2010; 6:e1001235.
15. Krathwohl MD, Schacker TW, Anderson JL. Abnormal presence of semimature dendritic cells that induce regulatory T cells in HIV-infected subjects. J Infect Dis 2006; 193:494-504.
16. Abel K, La Franco-Scheuch L, Rourke T et al. Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques. J Virol 2004; 78:841-54.
17. Biancotto A, Grivel JC, Iglehart SJ et al. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 2007; 109:4272-9.
18. Kornfeld C, Ploquin MJ, Pandrea I et al. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 2005; 115:1082-91.
19. Sabado RL, O'Brien M, Subedi A et al. Evidence of dysregulation of dendritic cells in primary HIV infection. Blood 2010; 116:3839-52.
20. Shedlock DJ, Silvestri G, Weiner DB. Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials. Nat Rev Immunol 2009; 9:717-28.
21. Brown KN, Wijewardana V, Liu X, Barratt-Boyes SM. Rapid influx and death of plasmacytoid dendritic cells in lymph nodes mediate depletion in acute simian immunodeficiency virus infection. PLoS Pathog 2009; 5:e1000413.
22. Barratt-Boyes SM, Soloff AC, Gao W et al. Broad cellular immunity with robust memory responses to simian immunodeficiency virus following serial vaccination with adenovirus 5- and 35-based vectors. J Gen Virol 2006; 87:139-49.
23. Kader M, Smith AP, Guiducci C, Wonderlich ER, Normolle D, Watkins SC, Barrat FJ, Barratt-Boyes SM. Blocking TLR7- and TLR9-mediated IFN-α production by plasmacytoid dendritic cells does not diminish immune activation in early SIV infection. PLoS Pathog 2013; 9:e1003530.
24. Harshyne LA, Watkins SC, Gambotto A, Barratt-Boyes SM. Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J Immunol 2001; 166:3717-23.
25. Brown KN, Barratt-Boyes SM. Surface phenotype and rapid quantification of blood dendritic cell subsets in the rhesus macaque. J Med Primatol 2009; 38:272-8.
26. Meier A, Alter G, Frahm N et al. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J Virol 2007; 81:8180-91.
27. Wonderlich ER, Wijewardana V, Liu X, Barratt-Boyes SM. Virus-encoded TLR ligands reveal divergent functional responses of mononuclear phagocytes in pathogenic simian immunodeficiency virus infection. J Immunol 2013; 190:2188-98.
28. Barratt-Boyes SM, Zimmer MI, Harshyne LA et al. Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines. J Immunol 2000; 164:2487-95.
29. Tschoep K, Manning TC, Harlin H, George C, Johnson M, Gajewski TF. Disparate functions of immature and mature human myeloid dendritic cells: implications for dendritic cell-based vaccines. J Leukoc Biol 2003; 74:69-80.
30. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811.
31. Chang JJ, Lacas A, Lindsay RJ et al. Differential regulation of toll-like receptor pathways in acute and chronic HIV-1 infection. AIDS 2012; 26:533-41.
32. Presicce P, Shaw JM, Miller CJ, Shacklett BL, Chougnet CA. Myeloid dendritic cells isolated from tissues of SIV-infected Rhesus macaques promote the induction of regulatory T cells. AIDS 2011; 26:263-73.
33. Choi YK, Fallert BA, Murphey-Corb MA, Reinhart TA. Simian immunodeficiency virus dramatically alters expression of homeostatic chemokines and dendritic cell markers during infection in vivo. Blood 2003; 101:1684-91.
34. Britschgi MR, Favre S, Luther SA. CCL21 is sufficient to mediate DC migration, maturation and function in the absence of CCL19. Eur J Immunol 2010; 40:1266-71.
35. Majumder B, Janket ML, Schafer EA, Schaubert K, Huang XL, Kan-Mitchell J, Rinaldo CR Jr, Ayyavoo V. Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape. J Virol 2005; 79:7990-8003.
36. Muthumani K, Hwang DS, Choo AY, Mayilvahanan S, Dayes NS, Thieu KP, Weiner DB. HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro. Int Immunol 2005; 17:103-16.
37. Kabashima K, Banks TA, Ansel KM, Lu TT, Ware CF, Cyster JG. Intrinsic lymphotoxin-β receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity 2005; 22:439-50.
38. Hasegawa A, Liu H, Ling B et al. The level of monocyte turnover predicts disease progression in the macaque model of AIDS. Blood 2009; 114:2917-25.
39. Burdo TH, Soulas C, Orzechowski K et al. Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathog 2010; 6:e1000842.
40. Laforge M, Campillo-Gimenez L, Monceaux V et al. HIV/SIV infection primes monocytes and dendritic cells for apoptosis. PLoS Pathog 2011; 7:e1002087.
41. Zimmer MI, Larregina AT, Castillo CM, Capuano S 3rd, Falo LD Jr, Murphey-Corb M, Reinhart TA, Barratt-Boyes SM. Disrupted homeostasis of Langerhans cells and interdigitating dendritic cells in monkeys with AIDS. Blood 2002; 99:2859-68.
42. Wijewardana V, Kristoff J, Xu C et al. Kinetics of myeloid dendritic cell trafficking and activation: impact on progressive, nonprogressive and controlled SIV infections. PLoS Pathog 2013; 9:e1003600.
43. Yang K, Puel A, Zhang S et al. Human TLR-7-, -8-, and -9-mediated induction of IFN-α/β and -λ is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity 2005; 23:465-78.